Interventions That Restore Awareness of Hypoglycemia in Adults With Type 1 Diabetes: A Systematic Review and Meta-analysis
Open accessThe DOI matches its Crossref record; 73 of the 77 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Impaired awareness of hypoglycemia (IAH) increases the risk of severe hypoglycemia (SH) sixfold and affects 30% of adults with type 1 diabetes (T1D). This systematic review and meta-analysis looks at the educational, technological, and pharmacological interventions aimed at restoring hypoglycemia awareness (HA) in adults with T1D. RESEARCH DESIGN AND METHODS: We searched The Cochrane Library, MEDLINE, Embase, Science Citation Index Expanded, Social Sciences Citation Index, PsycINFO, and CINAHL from inception until 1 October 2014. Included studies described HA status at baseline. Outcome measures were SH rates, change in HA, counterregulatory hormone responses, and glycemic control. RESULTS: Forty-three studies (18 randomized controlled trials, 25 before-and-after studies) met the inclusion criteria, comprising 27 educational, 11 technological, and 5 pharmacological interventions. Educational interventions included structured diabetes education on flexible insulin therapy, including psychotherapeutic and behavioral techniques. These were able to reduce SH and improve glycemic control, with greater benefit from the latter two techniques in improving IAH. Technological interventions (insulin pump therapy, continuous glucose monitoring, and sensor-augmented pump) reduced SH, improved glycemic control, and restored awareness when used in combination with structured education and frequent contact. Pharmacological studies included four insulin studies and one noninsulin study, but with low background SH prevalence rates. CONCLUSIONS: This review provides evidence for the effectiveness of a stepped-care approach in the management of patients with IAH, initially with structured diabetes education in flexible insulin therapy, which may incorporate psychotherapeutic and behavioral therapies, progressing to diabetes technology, incorporating sensors and insulin pumps, in those with persisting need.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Defining and Reporting Hypoglycemia in Diabetes
American Diabetes Association Workgroup on Hypoglycemia (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1245 · Cited by 1,146
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794 · cited 1×
“Hypoglycemia remains the major limiting factor toward achieving good glycemic control (1).”
BackgroundClarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.517 · Cited by 651
Cited by
Young-Hyman, D., de Groot, M., Hill-Briggs, F., Gonzalez, J. S., Hood, K., & Peyrot, M. (2016) · Diabetes Care · doi:10.2337/dc16-2053 · Cited by 1,072
“FoH and hypoglycemia unawareness often co-occur, and interventions aimed at treating one often benefit both (69).”
BackgroundHolt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
“Structured diabetes education in flexible insulin therapy, which may incorporate psychotherapeutic and behavioral therapies, progressing to diabetes technology, incorporating sensors and insulin pumps, are effective treatments in those with persisting need (125).”
Hering, B. J., Clarke, W. R., Bridges, N. D., Eggerman, T. L., Alejandro, R., Bellin, M. D., Chaloner, K., Czarniecki, C. W., Goldstein, J. S., Hunsicker, L. G., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1988 · Cited by 645
“Currently, the majority of patients presenting with problematic hypoglycemia are expected to experience resolution of severe hypoglycemia with optimal medical therapy that includes access to these interventions in a stepped-care approach (7,8,10).”
BackgroundInfluentialDiabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563
Amiel, S. A., Aschner, P., Childs, B., Cryer, P. E., de Galan, B. E., Frier, B. M., Gonder-Frederick, L., Heller, S. R., Jones, T., Khunti, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30315-2 · Cited by 526
Self-citation6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s006 · Cited by 486
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
van Beers, C. A. J., DeVries, J. H., Kleijer, S. J., Smits, M. M., Geelhoed-Duijvestijn, P. H., Kramer, M. H. H., Diamant, M., Snoek, F. J., & Serné, E. H. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30193-0 · Cited by 386
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05568-3 · Cited by 378
“Structured diabetes education in flexible insulin therapy, which may incorporate psychotherapeutic and behavioural therapies, progressing to diabetes technology, incorporating sensors and insulin pumps, are effective treatments in those with persisting need [125].”
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s005 · Cited by 362
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s005 · Cited by 339
“Interventions aimed at treating one often benefit both (224).”
BackgroundAmerican Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s005 · Cited by 445
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s005 · Cited by 299
“Interventions aimed at treating one often benefit both (251).”
BackgroundThe consequences of hypoglycaemia
Amiel, S. A. (2021) · Diabetologia · doi:10.1007/s00125-020-05366-3 · Cited by 223
Self-citationAmerican Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s004 · Cited by 182
“tions aimed at treating one often benefit both (93).”
Background6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s006 · Cited by 172
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s003 · Cited by 162
“Fear of hypoglycemia and hypoglycemia unawareness often co-occur, and interventions aimed at treating one often benefit both (86).”
BackgroundISPAD Clinical Practice Consensus Guidelines 2018: Diabetes education in children and adolescents
Phelan, H., Lange, K., Cengiz, E., Gallego, P., Majaliwa, E., Pélicand, J., Smart, C. E., & Hofer, S. E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12762 · Cited by 155
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes education in children and adolescents
Olinder, A. L., Deabreu, M., Greene, S. A., Haugstvedt, A., Lange, K., Majaliwa, E., Pais, V., Pélicand, J., Town, M., & Mahmud, F. H. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13418 · Cited by 161
Yale, J.-F., Paty, B., & Senior, P. A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.010 · Cited by 105
3. Comprehensive Medical Evaluation and Assessment of Comorbidities
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc17-s006 · Cited by 119
“Fear of hypoglycemia andhypoglycemia unawareness often co-occur, and interventions aimed at treating one often benefit both (74).”
BackgroundLittle, S. A., Speight, J., Leelarathna, L., Walkinshaw, E., Tan, H. K., Bowes, A., Lubina-Solomon, A., Chadwick, T. J., Stocken, D. D., Brennand, C., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2682 · Cited by 86
The role of structured education in the management of hypoglycaemia
Iqbal, A., & Heller, S. R. (2018) · Diabetologia · doi:10.1007/s00125-017-4334-z · Cited by 78
“When comparing head-to-head educational programmes that incorporate a psychological approach vs those that focus primarily on structured education of insulin therapy, no significant difference in severe hypoglycaemia has been observed [9].”
BackgroundMethodInfluentialCurrent Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified
Anderson, J. E., Gavin, J. R., & Kruger, D. F. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0303 · Cited by 77
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
Reddy, N., Verma, N., & Dungan, K. M. (2020) · MDText.com, Inc. eBooks · Cited by 108
Alhaddad, A. Y., Aly, H., Gad, H., Al-Ali, A. K., Sadasivuni, K. K., Cabibihan, J., & Malik, R. A. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.876672 · Cited by 77
“…glucose targets using different therapies (American Diabetes Association, 2020a; American Diabetes Association, 2020b), but are inherently associated with an increased risk of hypoglycemia (Ohkuma et al., 2021), especially in patients who have reduced awareness of hypoglycemia (Yeoh et al., 2015).”
BackgroundAmiel, S. A., Potts, L., Goldsmith, K., Jacob, P., Smith, E. L., Gonder-Frederick, L., Heller, S., Toschi, E., Brooks, A., Kariyawasam, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29488-x · Cited by 61
Self-citationIqbal, A., & Heller, S. R. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.06.004 · Cited by 64
Cook, A., DuBose, S. N., Foster, N. C., Smith, E. L., Wu, M., Margiotta, G., Rickels, M. R., Speight, J., de Zoysa, N., & Amiel, S. A. (2019) · Diabetes Care · doi:10.2337/dc19-0002 · Cited by 59
“Following the pathway for themanagement of hypoglycemia in T1D (14), some people regain awareness with educational and psychoeducational programs such as Dose Adjustment For Normal Eating (DAFNE) and HypoCOMPaSS (15,16), yet others continue with IAH and SH (9).”
BackgroundSelf-citationTechnology Integration: The Role of the Diabetes Care and Education Specialist in Practice
Isaacs, D. M., Cox, C. E., Schwab, K., Oser, T. K., RINKER, J. K., Mason, M. J., Greenwood, D. A., & Albanese-O’Neill, A. (2020) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721720935123 · Cited by 63
Choudhary, P., & Amiel, S. A. (2018) · Diabetologia · doi:10.1007/s00125-018-4566-6 · Cited by 52
“Education We have described how structured education programmes that teach self-management of flexible insulin regimens are at least as good in their impact on severe hypoglycaemia as technological solutions (reviewed in this issue of Diabetologia), demonstrating up to 50% reduction in the rates of severe hypoglycaemi…”
Self-citationHering, B. J., Ballou, C. M., Bellin, M. D., Payne, E. H., Kandeel, F., Witkowski, P., Alejandro, R., Rickels, M. R., & Barton, F. B. (2023) · Diabetologia · doi:10.1007/s00125-022-05804-4 · Cited by 51
Winkley, K., Upsher, R., Stahl, D., Pollard, D., Brennan, A., Heller, S., & Ismail, K. (2020) · Diabetic Medicine · doi:10.1111/dme.14264 · Cited by 47
Rondags, S. M. P. A., de Wit, M., Twisk, J. W., & Snoek, F. J. (2016) · Diabetes Care · doi:10.2337/dc16-1614 · Cited by 45
“(14) recently proposed an algorithm for offering psychoeducation combined with pump therapy and/or CGM to patients experiencing recurrent hypoglycemic events, but the evidence for using such tailored strategies is still lacking.”
BackgroundAmiel, S. A., Choudhary, P., Jacob, P., Smith, E. L., de Zoysa, N., Gonder-Frederick, L. A., Kendall, M., Heller, S. R., Brooks, A. M., Toschi, E., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030356 · Cited by 46
Self-citationNana, M., Moore, S. L., Ang, E., Lee, Z. X., & Bondugulapati, L. N. R. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107893 · Cited by 63
Charleer, S., Block, C. E. M. D., Nobels, F. R. E., Radermecker, R. P., Lowyck, I., Mullens, A., Scarnière, D., Spincemaille, K., Strivay, M., Weber, E., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1531 · Cited by 39
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 83
Garrett, C. J., Choudhary, P., Amiel, S. A., Fonagy, P., & Ismail, K. (2019) · Diabetic Medicine · doi:10.1111/dme.14109 · Cited by 37
“Am Diabetes Assoc; 2015;38(8):1592–609.”
BackgroundInfluentialSelf-citationHering, B. J., & O’Connell, P. J. (2016) · Xenotransplantation · doi:10.1111/xen.12228 · Cited by 37
“When compared against conventional CSII in a RCT in patients with T1D and IAH aged 4 to 50 yr, SAP with LGS reduced the combined rate of severe and moderate hypoglycemia with no change in glycated hemoglobin in either group [30].”
BackgroundMethodInfluentialGhandi, K., Pieri, B., Dornhorst, A., & Hussain, S. (2021) · Diabetes Therapy · doi:10.1007/s13300-020-00965-0 · Cited by 34
Vloemans, A. F., van Beers, C. A. J., de Wit, M., Cleijne, W., Rondags, S. M. P. A., Geelhoed-Duijvestijn, P. H. L. M., Kramer, M. H. H., Serné, E. H., & Snoek, F. J. (2017) · Diabetic Medicine · doi:10.1111/dme.13429 · Cited by 42
Cognitive deficits associated with impaired awareness of hypoglycaemia in type 1 diabetes
Hansen, T. I., Olsen, S. E., Haferstrom, E. C. D., Sand, T., Frier, B. M., Haberg, A. K., & Bjørgaas, M. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4233-3 · Cited by 31
“The modest cognitive impairment observed in people with IAH may contribute to their increased risk of developing severe hypoglycaemia, and emphasises the necessity to reinforce structured education by using psychotherapeutic and behavioural therapies, and utilising diabetes technologies to avoid SH [46].”
BackgroundYeoh, E. C. K., Lim, B. K., Fun, S., Tong, J. T., Yeoh, L. Y., Sum, C. F., Subramaniam, T., & Lim, S. C. (2016) · Nephrology · doi:10.1111/nep.12978 · Cited by 30
“Real-time CGM, when used properly, in conjunction with intensive insulin regimens is able to lower HbA1c in adults with type 1 diabetes,(8) and is useful in those with frequent hypoglycaemia and/or those with hypoglycaemia unawareness.(9,10) Similarly, retrospective CGM is able to provide detailed diagnostic informati…”
MethodSelf-citationShukla, V., Fuchs, P., Liu, A., Cohan, C. H., Dong, C., Wright, C. B., Pérez‐Pinzón, M. A., & Dave, K. R. (2018) · Translational Stroke Research · doi:10.1007/s12975-018-0622-2 · Cited by 30
“Recurrent exposure to hypoglycemia may lead to an impaired awareness of hypoglycemia [36, 105].”
BackgroundIslet Cell Transplantion: Update on Current Clinical Trials
Schuetz, C., & Markmann, J. F. (2016) · Current Transplantation Reports · doi:10.1007/s40472-016-0103-z · Cited by 34
Pieri, B. A., Bergin-Cartwright, G., Simpson, A., Collins, J., Reid, A., Karalliedde, J. J., Brackenridge, A., Hotopf, M. H., & Hussain, S. (2022) · Diabetes Care · doi:10.2337/dc21-2482 · Cited by 26
D’Amico, R. P., Pian, T. M., & Buschur, E. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.12.006 · Cited by 29
Kamusheva, M., Tachkov, K., Dimitrova, M. J., Mitkova, Z. E., García-Sáez, G., Hernando, M. E., Goettsch, W., & Petrova, G. I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.636959 · Cited by 32
Yu, X., Fan, M., Zhao, X., Ding, Y., Liu, X., Yang, S., & Zhang, X. (2023) · Diabetic Medicine · doi:10.1111/dme.15129 · Cited by 24
Siamashvili, M., Davis, H. A., & Davis, S. N. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1979391 · Cited by 28
“Most strikingly, the follow-up trial showed that the DAFNEstructured education decreased the rate of severe hypoglycemia from 1.7 ± 8.5 to 0.6 ± 3.7 episodes per person/year, as well as improving hypoglycemia recognition by 43% in those participants with IAH [86].”
BackgroundMethodInfluentialWho Should Be Considered for Islet Transplantation Alone?
Othonos, N., & Choudhary, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0847-6 · Cited by 24
Self-citationSampson, M., Bailey, M., Clark, J., Evans, M. L., Fong, R., Hall, H., Hambling, C. E., Hadley‐Brown, M., Morrish, N. J., Murphy, H. R., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.017 · Cited by 25
Mojdami, D., Mitchell, B. D., Spaepen, E., Syring, K. E., RABASA-LHORET, R. P. R., Punthakee, Z., Snoek, F. J., & Peyrot, M. F. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.08.104 · Cited by 22
Diabetes mellitus type 1 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Nikonova, T. V., Sukhareva, O. Y., Пекарева, Е. В., Ibragimova, L. I., Mikhina, M. S., Galstyan, G. R., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12505 · Cited by 22
Nattero‐Chávez, L., Pascual, E. L., de la Villa, E. D. L. C., Cebada, A. B., Ruiz, T., Tobar, A. Q., Lorenzo, M., Sánchez, C., Izquierdo, A., Luque‐Ramírez, M., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110627 · Cited by 19
Current and future therapies to treat impaired awareness of hypoglycemia
Macon, E. L., DEVORE, M. H., Lin, Y. K., MUSIC, M. B., WOOTEN, M., McMullen, C. A., Woodcox, A. M., MARKSBURY, A. R., Beckner, Z., Patel, B. V., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1271814 · Cited by 23
“…in hypoglycemia awareness and reduction in severe hypoglycemia with intensive hypoglycemia-focused education and close monitoring program, with non-differential effects between groups using more traditional or advanced glucose monitoring and insulin administration technologies (Yeoh et al., 2015).”
BackgroundIavicoli, I., Gambelunghe, A., Magrini, A., Mosconi, G., Soleo, L., Vigna, L., Trevisan, R., Bruno, A., Chiambretti, A., Scarpitta, A. M., et al. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.10.012 · Cited by 20
Minimising hypoglycaemia in the real world: the challenge of insulin
Mathieu, C. (2021) · Diabetologia · doi:10.1007/s00125-020-05354-7 · Cited by 16
Hatle, H., Bjørgaas, M. R., Skrivarhaug, T., Åsvold, B. O., Graveling, A. J., Frier, B. M., & Rø, T. B. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12951 · Cited by 15
“Nevertheless, at followup, more participants reported a change in awareness status from impaired to normal than vice versa, suggesting a beneficial effect from study participation, which is consistent with previous studies in adults and adolescents aged <18 years.(10,25) The differences in the key characteristics of I…”
BackgroundResultInfluentialJacob, P., Potts, L. C., Maclean, R., de Zoysa, N., Rogers, H., Gonder-Frederick, L. A., Smith, E. L., Kariyawasam, D., Brooks, A. M., Heller, S. R., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05679-5 · Cited by 19
“Structured education in insulin dose adjustment and technological advances in glucose monitoring and insulin delivery have brought about substantial reduction in SH in clinical trials [13], enabling creation of an evidence-based treatment pathway [7].”
BackgroundSelf-citationNovel Challenges in Aging with Type 1 Diabetes
Bispham, J. A., Hughes, A. S., Driscoll, K. A., & McAuliffe‐Fogarty, A. H. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01298-9 · Cited by 19
van Meijel, L. A., Rooijackers, H. M. M., Tack, C. J., & de Galan, B. E. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00087 · Cited by 17
Significant effect of group education in patients with diabetes type 1
Mouslech, Z., Somali, M., Livadas, S., Daramilas, C., Chatzi, A., Papagianni, M., Mastorakos, G. P., Savopoulos, C. G., & Hatzitolios, A. I. (2018) · HORMONES · doi:10.1007/s42000-018-0054-0 · Cited by 17
Buchmann, M., Tuncer, O., Auzanneau, M., Eckert, A. J., Rosenbauer, J., Reitzle, L., Heidemann, C., Holl, R. W., & Thamm, R. (2023) · PubMed Central · doi:10.25646/11439 · Cited by 29
Automated Insulin Delivery: The Artificial Pancreas Technical Challenges
Hernando, M. E., García-Sáez, G., Aguilera, E. J. G., Gandía, C. P., & Rodríguez-Herrero, A. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001086 · Cited by 17
Soukup, T., Hull, L., Smith, E. L., Healey, A., Bakolis, I., Amiel, S. A., Sevdalis, N., & PWD Group (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030370 · Cited by 17
Self-citationRestoration of Hypoglycemia Awareness Alters Brain Activity in Type 1 Diabetes
Nwokolo, M., Amiel, S. A., O’Daly, O., Macdonald, I. A., Zelaya, F. O., & Choudhary, P. (2020) · Diabetes Care · doi:10.2337/dc20-1250 · Cited by 16
Self-citationLega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12
“Numerous psychoeducational programs have been shown to reduce the prevalence of IAH and related frequency of hypo-glycemia (i.e. HypoCOMPaSS, BGAT, HAATT, and DAFNE-HART) [82,93,112 e 114].”
BackgroundHatle, H., Skrivarhaug, T., Bjørgaas, M. R., Åsvold, B. O., & Rø, T. B. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111093 · Cited by 12
Roze, S., Smith‐Palmer, J., Portu, S. D., Delbaere, A., Brouwer, B. D., & de Valk, H. W. (2019) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s186298 · Cited by 13
Valle, C. G.-D., Marco‐Expósito, J. F., Bosch‐Sierra, N., Zaragozá, B., Solá, E., Montoya‐Castilla, I., Morillas, C., & Bañuls, C. (2022) · Journal of Clinical Nursing · doi:10.1111/jocn.16270 · Cited by 10
Zekarias, K., Kumar, A. F., Moheet, A. A., & Seaquist, E. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.08.015 · Cited by 11
Sepúlveda, E., Jacob, P., Poínhos, R., Carvalho, D. M., Vicente, S., Smith, E. L., Shaw, J., Speight, J., Choudhary, P., de Zoysa, N., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05847-7 · Cited by 12
Self-citationBilal, A., Yi, F., Whitaker, K. J., IGUDESMAN, D. A., Pratley, R. E., & Casu, A. (2024) · Diabetes Care · doi:10.2337/dc24-0201 · Cited by 10
Kuniß, N., Kramer, G., Muller, N., Kloos, C., Wolf, G., & Müller, U. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0881-x · Cited by 8
“There are a number of interventions available to restore impaired awareness of hypoglycaemia [34].”
BackgroundShen, Z., Xu, J., Yin, W. H., Liu, Q., Fan, M., & Luo, C. (2022) · Contemporary Nurse · doi:10.1080/10376178.2022.2071311 · Cited by 7
“Various strategies have been used in this context, including educational approaches, technological interventions, and pharmacotherapies (Yeoh et al., 2015), leading to some positive physical and psychological health outcomes for patients with IAH; nevertheless, a significant proportion of patients…”
MethodCanha, D., Choudhary, P., Cosson, E., Banu, I., Barraud, S., Valéro, R., Ronci, N., Delenne, B., Dufaitre, L., Vidal-Trécan, T., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06536-x · Cited by 13
“Moreover, a recent systematic review [33] reinforces that although AID systems may offer some advantages, psychoeducational interventions remain the cornerstone of IAH management.”
Self-citationBotan, V., Law, G. R., Laparidou, D., Rowan, E., Smith, M. D., Ridyard, C. H., Brewster, A., Spaight, R., Spurr, K., Mountain, P., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14612 · Cited by 8
Impaired awareness of hypoglycaemia
Amiel, S. A. (2022) · British Journal of Diabetes · doi:10.15277/bjd.2022.358 · Cited by 7
Self-citationYang, A., Yu, J., Cheung, J. T. K., Chan, J. C. N., & Chow, E. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16386 · Cited by 12
The impact of technology on impaired awareness of hypoglycaemia in type 1 diabetes
Berry, S. A., Goodman, I., Heller, S. R., & Iqbal, A. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251346260 · Cited by 8
“30 Glucose Self-monitoring’ (HypoCOMPaSS) study have showed that less stringent avoidance of hypo-glycaemia over a prolonged period of time can achieve similar results in terms of symptom restoration and normalisation of the glycaemic thresholds required to initiate counter-regulatory responses.”
Baxter, F., Baillie, N., Dover, A. R., Stimson, R. H., Gibb, F. W., & Forbes, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297601 · Cited by 7
“People with T1D can regain hypoglycaemia awareness through avoidance of hypoglycaemia [2,10–12].”
BackgroundResolution on the results of the First All-Russian Forum "Therapeutic Education in Endocrinology"
Shestakova, M. V., Mayorov, A. Y., Surkova, E. V., Galstyan, G. R., As, A., Antsiferov, M. B., Starostina, E. G., Mel'nikova, O. G., Ibragimova, L. I., Андрианова, Е. А., et al. (2022) · Diabetes Mellitus · doi:10.14341/dm12943 · Cited by 6
Serné, E. H., van den Berg, I. K., Racca, C., van Raalte, D. H., Kramer, M. H. H., de Wit, M., & Snoek, F. J. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0232 · Cited by 6
“11 These data and a meta-analysis 10 provide the rationale for a stepped-care approach in the management of patients with IAH, initially with structured diabetes education in flexible insulin therapy, which may incorporate psychotherapeutic and behavioral therapies, progressing to diabetes…”
Huang, B., Jiang, Q., Wu, T., Shen, Q., Wang, W., Wang, S., Huang, Y., Wang, S., Huang, P., Lin, M., et al. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00959-x · Cited by 8
Hypoglycemia in Diabetes: Challenges and Opportunities in Care
Kreider, K. E., Padilla, B. I., & Pereira, K. C. (2017) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2016.08.032 · Cited by 6
Perea, V., Giménez, M., Amor, A. J., Bellart, J., Conget, I., & Vinagre, I. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.06.015 · Cited by 11
Pedrosa, H. C., Braver, J. D., Rolim, L. C., Schmid, H., Calsolari, M. R., & Odriozola, A. (2019) · Alad · doi:10.24875/alad.18000352 · Cited by 6
Le patient sentinelle : une anticipation des crises dans les maladies chroniques
Crozet, C., Golay, A., & d’Ivernois, J.-F. (2018) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30180-9 · Cited by 6
Alassaf, A. A., Gharaibeh, L. F., Ibrahim, S., Alkhalaileh, S., & Odeh, R. (2023) · Pediatric Diabetes · doi:10.1155/2023/7258136 · Cited by 5
“However, there are reports that educational programs may play a role in achieving better glycemic control and reducing the incidence of hypoglycemia [25, 36].”
Brusadelli, E., Tomasich, A., Bruno, S., Romanazzi, A., Dagani, R., & Porcelli, P. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000486486 · Cited by 4
Dey, A. K., Gokalani, R. A., Kale, M. C., Sankar, P., Saboo, B., Maheshwari, A., Jaggi, S., Jagadeesha, A., Panchal, D., Chawla, M. S., et al. (2024) · Journal of Diabetology · doi:10.4103/jod.jod_121_23 · Cited by 5
Haddadi, D., Rosolowsky, E. T., Pacaud, D., McKeen, J. A., Young, K., Madrick, B., Domaschuk, L., Sargious, P. M., Conroy, S., & Senior, P. A. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.08.097 · Cited by 5
Escudero, C., Husain, A., & Arnaout, A. (2024) · AACE Clinical Case Reports · doi:10.1016/j.aace.2024.03.001 · Cited by 4
“6,7 National diabetes guidelines additionally recommend structured hypoglycemia education and prevention interventions such as the Blood Glucose Awareness Training Program.”
BackgroundThomakos, P., Mitrakou, A., Kepaptsoglou, O., Taraoune, I., Barreto, C., & Zoupas, C. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0889-7598 · Cited by 5
Jokiaho, A. J., Winchester, M., & Donovan, C. M. (2022) · Diabetes · doi:10.2337/db21-0859 · Cited by 4
Kieu, A., Govender, R. D., Östlundh, L., & King, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050027 · Cited by 3
Daramilas, C., Papagianni, M., Ntafi, C., Mastorakos, G. P., & Sardeli, C. (2025) · Nutrients · doi:10.3390/nu17061026 · Cited by 5
“A recent meta-analysis confirmed the importance of such interventions combined with technology-based programs in improving hypoglycemia awareness and glycemic control in patients with T1DM [42].”
Metadata
- Authors
- Yeoh, E., Choudhary, P., Nwokolo, M., Ayis, S., & Amiel, S. A.
- Affiliations
- King's College Hospital (GB)
- King's College London (GB)
- Corresponding author
- Yeoh, Ester
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2015-07-14
- Volume
- 38
- Issue
- 8
- Pages
- 1592-1609
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2102956124
- Cited by
- 154
- References
- 77
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 10 · 2023: 9 · 2022: 23 · 2021: 12 · 2020: 14 · 2019: 21 · 2018: 19 · 2017: 11 · 2016: 16 · 2015: 1
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- green
- kclpure.kcl.ac.uk
- Licence
- other-oa
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, other-oa)
- Funders
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- impaired awareness of hypoglycemia, type 1 diabetes, severe hypoglycemia, diabetes education, psychotherapeutic interventions, behavioral interventions, insulin pump therapy, continuous glucose monitoring, sensor-augmented pump, glycemic control, counterregulatory hormones, stepped care
- MeSH terms
- Adolescent, Adult, Aged, Awareness, Behavior Therapy, Blood Glucose, Diabetes Mellitus, Type 1, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Middle Aged, Patient Education as Topic, Blood Glucose Self-Monitoring, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.